While the majority of practical outcomes in healthy Longevity will be driven by precision health technologies, they will also require an assembly of other, non-biomedical components, including traditional financial products and services along with tech-enabled financial sectors such as InsurTech and WealthTech. The report delivers the overview of the trends, funding activity, risk assessment for a variety of Longevity finance subsectors.